These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16544004)

  • 1. Persistence of hyperprolactinemia after treatment of primary hypothyroidism and withdrawal of long term use of estrogen: are the tuberoinfundibular dopaminergic neurons permanently lesioned?
    Casulari LA; Celotti F; Naves LA; Domingues L; Papadia C
    Arq Bras Endocrinol Metabol; 2005 Jun; 49(3):468-72. PubMed ID: 16544004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen inhibits tuberoinfundibular dopaminergic neurons but does not cause irreversible damage.
    Morel GR; Carón RW; Cónsole GM; Soaje M; Sosa YE; Rodríguez SS; Jahn GA; Goya RG
    Brain Res Bull; 2009 Dec; 80(6):347-52. PubMed ID: 19744546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced tuberoinfundibular dopaminergic neuron activity in thyroidectomized, ovariectomized and estrogen-treated rats with hyperprolactinemia.
    Yang JY; Pan JT
    Neuroendocrinology; 1994 Jun; 59(6):520-7. PubMed ID: 8084375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced prolactin secretion in patients with primary hypothyroidism during thyroid replacement.
    Sato S; Hanew K; Sasaki A; Shimizu Y; Murakami O; Fukazawa H; Sakurada T; Saito S; Yoshinaga K
    Tohoku J Exp Med; 1984 Dec; 144(4):425-31. PubMed ID: 6528338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin regulation of tuberoinfundibular dopaminergic neurons: immunoneutralization studies.
    Hentschel K; Fleckenstein AE; Toney TW; Lawson DM; Moore KE; Lookingland KJ
    Brain Res; 2000 Jan; 852(1):28-36. PubMed ID: 10661492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prolactin-releasing peptide on tuberoinfundibular dopaminergic neuronal activity and prolactin secretion in estrogen-treated female rats.
    Yuan ZF; Yang SC; Pan JT
    J Biomed Sci; 2002; 9(2):112-8. PubMed ID: 11914577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin inhibition at the end of lactation programs for a central hypothyroidism in adult rat.
    Bonomo IT; Lisboa PC; Passos MC; Alves SB; Reis AM; de Moura EG
    J Endocrinol; 2008 Aug; 198(2):331-7. PubMed ID: 18490438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent increase of PRL after oral contraceptive treatment. Alterations in dopaminergic regulation as possible etiology.
    Alvarez-Tutor E; Forga-LLenas L; Rodriguez-Erdozain R; Goñi-Iriarte MJ; Mendendez-Torre E; Alvarez-Tutor J
    Arch Gynecol Obstet; 1999 Nov; 263(1-2):45-50. PubMed ID: 10728629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine regulation of prolactin and TSH secretion in hypothyroidism.
    Gerasimov G; Chernova T; Goncharov N
    Acta Med Austriaca; 1992; 19 Suppl 1():86-8. PubMed ID: 1519463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
    Shah GV; Shyr SW; Grosvenor CE; Crowley WR
    Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic hyperprolactinemia on tuberoinfundibular dopaminergic neurons: histofluorescence in aged and in diethylstilbestrol-treated male rats.
    Phelps CJ; Collier TJ; Bartke A
    Brain Res; 1987 May; 411(1):108-19. PubMed ID: 3300842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian steroids influence the activity of neuroendocrine dopaminergic neurons.
    DeMaria JE; Livingstone JD; Freeman ME
    Brain Res; 2000 Oct; 879(1-2):139-47. PubMed ID: 11011015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
    Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
    J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrity of central dopaminergic system in women with postpartum hyperprolactinemia.
    Rao R; Scommegna A; Frohman LA
    Am J Obstet Gynecol; 1982 Aug; 143(8):883-7. PubMed ID: 7102764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prolactin and TSH response in functional tests in patients with primary hypothyroidism in a context of hyperprolactinemia].
    Chernova TO; Kolesnikova GS; Mudretsova SV; Serpukhovitin SIu; Goncharov NP; Gereasimov GA
    Probl Endokrinol (Mosk); 1994; 40(5):16-8. PubMed ID: 7899431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of hypothalamic hyperprolactinemia.
    Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
    J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of in vitro dopamine synthesis in the median eminence of rats with haloperidol-induced hyperprolactinemia and bromocriptine-induced hypoprolactinemia.
    Arita J; Kimura F
    Endocrinology; 1986 Oct; 119(4):1666-72. PubMed ID: 3019639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin and thyrotropin responses to thyrotropin-releasing hormone and metoclopramide in men with chronic alcoholism.
    Röjdmark S; Adner N; Andersson DE; Austern J; Lamminpää K
    J Clin Endocrinol Metab; 1984 Oct; 59(4):595-600. PubMed ID: 6434573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rapid 'tonic' and the delayed 'induction' components of the prolactin-induced activation of tuberoinfundibular dopaminergic neurons following the systemic administration of prolactin.
    Demarest KT; Riegle GD; Moore KE
    Neuroendocrinology; 1986; 43(3):291-9. PubMed ID: 3090463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frequency of increased thyrotropin in women with hyperprolactinemia].
    Carranza-Lira S; Daza-Carrasco ML; Chán-Verdugo R
    Rev Med Inst Mex Seguro Soc; 2017; 55 Suppl 1():S53-S57. PubMed ID: 28212475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.